To further investigate the correlation between prostate cancer progression and blood adiponectin and leptin concentrations, we divided the patients into groups with various cutoffs for adiponectin and leptin concentrations and performed statistical analysis to determine whether a correlation occurred with the risk of biochemical recurrence. This evidence concerns the gene ADIPOQ and prostate carcinoma.